In conclusion, our findings suggest that low IL-33 levels are linked to greater stroke severity and poorer outcomes, reinforcing the potential of IL-33 as a biomarker for predicting adverse prognosis following acute ischemic stroke. This evidence concerns the gene IL33 and Stroke.